Record-Breaking Price Movement
On 8 September 2026, India Glycols Ltd’s share price surged to Rs.293.25, representing a 4.99% increase on the day. This new peak eclipses all previous highs, setting a fresh benchmark for the company’s equity valuation. The stock outperformed its sector by 4.13% on the same day, underscoring its relative strength within the commodity chemicals industry.
The stock has demonstrated remarkable momentum, registering gains for five consecutive trading sessions. Over this period, it has delivered a cumulative return of 21.78%, signalling robust investor interest and positive market sentiment. Intraday volatility was elevated at 5.15%, reflecting active trading and dynamic price discovery.
Technical Indicators and Moving Averages
India Glycols is currently trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment indicates a strong bullish trend, confirmed by technical signals such as the MACD and Bollinger Bands, which remain positive on both weekly and monthly timeframes. The stock’s Relative Strength Index (RSI) shows a bearish signal on the weekly chart but no significant signal on the monthly chart, suggesting some short-term caution amid the broader upward trend.
The immediate support level stands at Rs.171.49, coinciding with the 52-week low, while the stock has decisively surpassed major resistance points at Rs.218.22 (200-day moving average), Rs.229.47 (100-day moving average), and Rs.246.24 (20-day moving average). The recent trend shift to bullish was noted on 4 September 2026 at a price of Rs.266, further reinforcing the positive momentum.
Valuation Metrics Reflect Attractive Pricing
Despite the stock’s record high, valuation multiples remain modest. The price-to-earnings (P/E) ratio stands at 6x on a trailing twelve months basis, while the price-to-book value (P/BV) is 0.64x. Enterprise value multiples such as EV/EBITDA and EV/EBIT are 5.25x and 6.95x respectively, indicating reasonable valuation relative to earnings and operating profit. The PEG ratio is exceptionally low at 0.01x, suggesting that the stock’s price growth is not yet fully reflected in earnings growth expectations.
Dividend metrics also contribute to the stock’s appeal, with a current dividend yield of 4.34% and a latest dividend payout of Rs.1.62 per share. The ex-dividend date was 23 March 2026, and the dividend payout ratio remains conservative at 13.41%, signalling a balanced approach to shareholder returns and reinvestment.
Long-Term Performance Outpaces Benchmarks
India Glycols Ltd has delivered exceptional returns over extended periods, significantly outperforming the benchmark Sensex index. Over the past year, the stock has appreciated by 65.20%, compared to a Sensex decline of 6.26%. Year-to-date gains stand at 33.24%, while the three-year and five-year returns are an impressive 263.51% and 292.21% respectively, dwarfing the Sensex’s 13.71% and 30.01% gains over the same periods.
Over a decade, the stock’s growth has been extraordinary, with a cumulative return of 2361.72%, far exceeding the Sensex’s 160.74%. This long-term outperformance highlights the company’s ability to generate value consistently within the commodity chemicals sector.
Financial and Quality Assessment
India Glycols’ recent financial trends indicate a positive trajectory. The company reported its highest half-yearly return on capital employed (ROCE) at 11.79%, alongside a strong operating profit to interest coverage ratio of 6.73 times. Net sales for the latest quarter reached ₹1,130.39 crores, with profit before tax (excluding other income) at ₹122.50 crores and net profit after tax at ₹96.83 crores. Earnings per share (EPS) for the quarter stood at ₹14.45, marking the highest levels recorded.
However, cash and cash equivalents were at their lowest half-yearly level of ₹49.83 crores, which is a factor to monitor in the company’s liquidity profile. The debt-equity ratio improved to 0.58 times, reflecting a reduction in leverage and a more conservative capital structure.
Quality metrics classify India Glycols as a below-average quality company based on long-term financial performance, with moderate leverage and below-average growth rates. The company’s five-year sales compound annual growth rate (CAGR) is 8.63%, while EBIT growth over the same period is 18.75%. Average return on equity (ROE) and ROCE remain modest at 8.69% and 8.60% respectively. Institutional holdings are relatively low at 7.46%, and there is no promoter share pledging.
Delivery Volumes and Market Capitalisation
Trading activity has been robust, with delivery volumes increasing by 56.02% over the past month and a 98.65% rise in delivery volumes on 8 September compared to the five-day average. The stock is classified as a small-cap company, with a Mojo Score of 60.0 and a current Mojo Grade of Hold, upgraded from Sell on 4 September 2026.
The stock’s recent performance has been markedly superior to the Sensex, which declined by 0.53% on the day and by 1.58% over the past week, emphasising India Glycols’ relative strength in a challenging market environment.
Summary of Key Metrics
India Glycols Ltd’s stock price reaching Rs.293.25 on 8 September 2026 represents a landmark achievement, supported by strong technical indicators, attractive valuation multiples, and solid financial performance. The company’s ability to sustain gains over multiple time horizons, coupled with a healthy dividend yield and improving leverage ratios, underscores its resilience within the commodity chemicals sector.
While quality assessments suggest areas for improvement, the stock’s consistent outperformance relative to the broader market and sector peers highlights its significance as a noteworthy equity in the current market landscape.
